title: [What is new in . . . Infectious diseases: Advancements and setbacks].
authors.forename: Pierre
authors.initials: P
authors.lastname: Tattevin
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000191:economics / Q000382:microbiology*; D065632:Chikungunya Fever / Q000517:prevention & control; D003140:Communicable Disease Control / Q000191:economics / Q000639:trends*; D003141:Communicable Diseases / Q000628:therapy; D024901:Drug Resistance, Multiple, Bacterial; D024921:Drug Resistance, Multiple, Viral; D005602:France; D015658:HIV Infections / Q000150:complications / Q000191:economics / Q000628:therapy*; D019142:Hemorrhagic Fever, Ebola / Q000517:prevention & control; D006526:Hepatitis C / Q000150:complications / Q000191:economics / Q000628:therapy*; D006801:Humans; D055552:Infectious Disease Medicine / Q000191:economics / Q000639:trends*
chemical_list: D000900:Anti-Bacterial Agents; D000998:Antiviral Agents